0.57Open0.57Pre Close0 Volume7 Open Interest35.00Strike Price0.00Turnover800.83%IV54.25%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.57Extrinsic Value100Contract SizeAmericanOptions Type-0.0334Delta0.0021Gamma132.04Leverage Ratio-0.5682Theta-0.0001Rho-4.40Eff Leverage0.0034Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet